Literature DB >> 19070592

Palmitate alters neuregulin signaling and biology in cardiac myocytes.

Thomas A Miller1, Basak Icli, Gregory M Cote, Nathan K Lebrasseur, Steve C Borkan, David R Pimentel, Xuyang Peng, Douglas B Sawyer.   

Abstract

The saturated fatty acid palmitate alters normal cell function via disruption of cell signaling, and this effect has been implicated in the end-organ damage associated with dyslipidemia. Neuregulin-1beta (NRG-1beta) is a growth and survival factor in cardiac myocytes. We tested the hypothesis that palmitate alters NRG-1beta signaling and biology in isolated neonatal rat cardiac myocytes. Palmitate treatment inhibited NRG-1beta activation of the PI3-kinase/Akt pathway in myocytes. We found that the pro-apoptotic activity of palmitate was increased by NRG-1beta treatment. The effects of palmitate on NRG-1beta signaling and survival were reversed by the mono-unsaturated fatty acid oleate. Under control conditions NRG-1beta decreases p53 expression in myocytes. In the presence of palmitate, NRG-1beta caused an increase in p53 expression, bax multimer formation, concurrent with degradation of mdm2, a negative regulator of p53. Thus in the presence of palmitate NRG-1beta activates pro-apoptotic, rather than pro-survival signaling in cardiac myocytes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19070592      PMCID: PMC2654183          DOI: 10.1016/j.bbrc.2008.11.150

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  46 in total

1.  Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1beta/erbB4 signaling.

Authors:  Yukio Kuramochi; Gregory M Cote; Xinxin Guo; Nathan K Lebrasseur; Lei Cui; Ronglih Liao; Douglas B Sawyer
Journal:  J Biol Chem       Date:  2004-09-21       Impact factor: 5.157

2.  The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells.

Authors:  Anjali Naresh; Weiwen Long; Gregory A Vidal; William C Wimley; Luis Marrero; Carolyn I Sartor; Sian Tovey; Timothy G Cooke; John M S Bartlett; Frank E Jones
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

3.  Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling.

Authors:  Jose Antonio Chavez; William L Holland; Julia Bär; Konrad Sandhoff; Scott A Summers
Journal:  J Biol Chem       Date:  2005-03-17       Impact factor: 5.157

4.  Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure.

Authors:  Fen-Fen Liu; James R Stone; Adam J T Schuldt; Katashi Okoshi; Marina P Okoshi; Masaharu Nakayama; Kalon K L Ho; Warren J Manning; Mark A Marchionni; Beverly H Lorell; James P Morgan; Xinhua Yan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-04-15       Impact factor: 4.733

5.  Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate.

Authors:  C Schmitz-Peiffer; D L Craig; T J Biden
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

6.  Neuregulin in cardiac hypertrophy in rats with aortic stenosis. Differential expression of erbB2 and erbB4 receptors.

Authors:  S Rohrbach; X Yan; E O Weinberg; F Hasan; J Bartunek; M A Marchionni; B H Lorell
Journal:  Circulation       Date:  1999-07-27       Impact factor: 29.690

7.  NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK.

Authors:  R R Baliga; D R Pimental; Y Y Zhao; W W Simmons; M A Marchionni; D B Sawyer; R A Kelly
Journal:  Am J Physiol       Date:  1999-11

8.  Oleate prevents palmitate-induced cytotoxic stress in cardiac myocytes.

Authors:  Thomas A Miller; Nathan K LeBrasseur; Gregory M Cote; Mario P Trucillo; David R Pimentel; Yasuo Ido; Neil B Ruderman; Douglas B Sawyer
Journal:  Biochem Biophys Res Commun       Date:  2005-10-14       Impact factor: 3.575

9.  Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes: implications for herceptin-induced cardiomyopathy.

Authors:  Luanda P Grazette; Wolfgang Boecker; Takashi Matsui; Marc Semigran; Thomas L Force; Roger J Hajjar; Anthony Rosenzweig
Journal:  J Am Coll Cardiol       Date:  2004-12-07       Impact factor: 24.094

10.  Differential effects of saturated and unsaturated fatty acid diets on cardiomyocyte apoptosis, adipose distribution, and serum leptin.

Authors:  Isidore C Okere; Margaret P Chandler; Tracy A McElfresh; Julie H Rennison; Victor Sharov; Hani N Sabbah; Kou-Yi Tserng; Brian D Hoit; Paul Ernsberger; Martin E Young; William C Stanley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-01-27       Impact factor: 4.733

View more
  10 in total

1.  PPARα agonist prevented the apoptosis induced by glucose and fatty acid in neonatal cardiomyocytes.

Authors:  W Q Nan; T Q Shan; X Qian; W Ping; G A Bing; L L Ying
Journal:  J Endocrinol Invest       Date:  2010-03-30       Impact factor: 4.256

2.  Astragalus polysaccharide suppresses palmitate-induced apoptosis in human cardiac myocytes: the role of Nrf1 and antioxidant response.

Authors:  Ji Zhang; Jian-Yun Gu; Zhi-Song Chen; Kai-Chen Xing; Bing Sun
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

3.  Exercise training and return to a well-balanced diet activate the neuregulin 1/ErbB pathway in skeletal muscle of obese rats.

Authors:  Gaël Ennequin; Nathalie Boisseau; Kevin Caillaud; Vivien Chavanelle; Maude Gerbaix; Lore Metz; Monique Etienne; Stéphane Walrand; Aurélie Masgrau; Christelle Guillet; Daniel Courteix; Airu Niu; Yi-Ping Li; Fréderic Capel; Pascal Sirvent
Journal:  J Physiol       Date:  2015-05-14       Impact factor: 5.182

4.  Cardiomyocyte-specific deletion of GSK-3β leads to cardiac dysfunction in a diet induced obesity model.

Authors:  Manisha Gupte; Samvruta Tumuluru; Jennifer Y Sui; Anand Prakash Singh; Prachi Umbarkar; Shan S Parikh; Firdos Ahmad; Qinkun Zhang; Thomas Force; Hind Lal
Journal:  Int J Cardiol       Date:  2018-02-03       Impact factor: 4.164

Review 5.  Neuregulin as a heart failure therapy and mediator of reverse remodeling.

Authors:  Cristi L Galindo; Sergey Ryzhov; Douglas B Sawyer
Journal:  Curr Heart Fail Rep       Date:  2014-03

Review 6.  Neuregulin in cardiovascular development and disease.

Authors:  Oghenerukevwe Odiete; Michael F Hill; Douglas B Sawyer
Journal:  Circ Res       Date:  2012-10-26       Impact factor: 17.367

7.  Intravenous glial growth factor 2 (GGF2) isoform of neuregulin-1β improves left ventricular function, gene and protein expression in rats after myocardial infarction.

Authors:  Michael F Hill; Amish V Patel; Abigail Murphy; Holly M Smith; Cristi L Galindo; Laura Pentassuglia; Xuyang Peng; Carrie G Lenneman; Oghenerukevwe Odiete; David B Friedman; Marvin W Kronenberg; Siyuen Zheng; Zhongming Zhao; Yanna Song; Frank E Harrell; Maya Srinivas; Anindita Ganguly; Jennifer Iaci; Tom J Parry; Anthony O Caggiano; Douglas B Sawyer
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

8.  Alteration of serum neuregulin 4 and neuregulin 1 in gestational diabetes mellitus.

Authors:  Lei Zhang; Bi Lu; Wenhua Wang; Shifeng Miao; Shuru Zhou; Xingbo Cheng; Jie Zhu; Changmei Liu
Journal:  Ther Adv Endocrinol Metab       Date:  2021-10-08       Impact factor: 3.565

9.  Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure.

Authors:  Oghenerukevwe Odiete; Ewa A Konik; Douglas B Sawyer; Michael F Hill
Journal:  Cardiovasc Diabetol       Date:  2013-03-27       Impact factor: 9.951

10.  Neuregulin 1 Improves Glucose Tolerance in db/db Mice.

Authors:  Gaël Ennequin; Nathalie Boisseau; Kevin Caillaud; Vivien Chavanelle; Monique Etienne; Xinyan Li; Pascal Sirvent
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.